Get Detailed Profiles of Medtech Start-Ups:
Purchase now and get access to thousands of innovative medtech startups. Access Includes discreet details, CEO presentations, executive summaries, strategic plans, and much more.





Presenting Companies at Q1 2019 EMT Spotlight:

Click here to apply to present your company in the upcoming EMT Spotlight.

Purchase access and get detailed insights on all of the companies below via CEO presentations (audio and slides), executive summaries, and much more. Plus leverage our private partnering tool to request additional information and meetings with CEOs.

Invizius - Patient outcome on dialysis are dismal. Life expectancy is slashed by two-thirds, and over half of patients die from cardiovascular complications. A leading cause of complications is the repeated inflammatory insult to the cardiovascular system provoked by the procedure itself. Invizius's H-Guard product is an accessory to dialysis machines which integrates with current setup procedures, and prevents the inflammatory reaction on patients and the ensuing complications, costs and mortality. (View Sample Presentation)
Suono Bio - Use of low frequency ultrasound to deliver unformulated therapeutics such as mRNA, siRNA, macromolecules directly into tissue. Initial focus on gastrointestional system and skin diseases. (View Sample Presentation)
SUTUREGARD Medical - We are on a mission to close more wounds. Our technology allows surgeons to quickly yet gently stretch skin and close wounds that are not able to be closed with standard suture technique. This makes a whole category or wounds that usually require a skin graft or skin flap now closeable in a simple linear fashion. Our target market is skin cancer surgery. (View Sample Presentation)
Vectorious Medical Technologies - Implantable long-term hemodynamic monitoring technology for use in congestive heart failure patients (View Sample Presentation)
PRESENTER - More companies coming soon


Sample EMT Spotlight Profile
Below is a sample profile from our last event. This type of insight is available for every company being profiled in our upcoming Spotlight.


Presenter: Boaz Assaf, CEO
Financing Status: Seeking Funding
Round: Series C
Amount: $6-$8M
Development Status: CE Marked, Pilot clinical trial completed ready to launch FDA pivotal trial
Sales Projection: $7,725,000 in 2021
Seeking Partners: Financing, M&A, Licensing




Sponsors:



Contact Us

Need help finding medtech research? Let us help you!